Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
June 1, 2006Clinical Pharmacology & Therapeutics

Exposure of atorvastatin is unchanged but lactone and acid metabolites are increased several-fold in patients with atorvastatin-induced myopathy

View Full Paper
Ask AI
Bookmark
Share

Authors

MHMatthias HermannMBMartin P. BogsrudEMEspen Molden

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Hermann et al. (2006) studied this question.

synapsesocial.com/papers/6a86f13848ef9afcd2a24febhttps://doi.org/10.1016/j.clpt.2006.02.014
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1OATP-C(OATP01B1)*15 is associated with statin-induced myopathy in hypercholesterolemic patients2005 · 25 citations
  2. 2Statin-Associated Myopathy with Normal Creatine Kinase Levels2002 · 564 citations
  3. 3Effect of itraconazole on the pharmacokinetics of atorvastatin*1998 · 301 citations
  4. 4Reversible Myopathy after Statin Therapy in Patients with Normal Creatine Kinase Levels2003 · 14 citations